Showing 2640 results
- Media Release /Findings across six countries and four continents showed a reduction in quality of life for majority (71%) of patients living with myeloproliferative neoplasms (MPNs)[1] Patients…
- Media Release /ASSIST-FL trial demonstrates equivalent safety, efficacy, pharmacokinetics and pharmacodynamics of Sandoz proposed biosimilar rituximab (GP2013) to the reference product[1] Interim data in over…
- Media Release /82% (41 of 50) of patients achieved complete remission or complete remission with incomplete blood count recovery in interim analysis of Novartis study (ELIANA) ELIANA, the first global CAR T…
- Story /
- Story /
A Novartis experimental drug in clinical trial aims to block liver cancer growth
- Story /
Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.
- Story /
A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.
- Story /
These stories offer a glimpse into the lives of people touched by a new era of medicine.
- Story /
The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
- Story /
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
Pagination
- ‹ Previous page
- 1
- …
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- …
- 264
- › Next page